Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double C2-like domains, beta pseudogene (ENSG00000267295) is a genomic sequence similar to the functional double C2-like domain beta (DOC2B) gene but contains defects that make it incapable of encoding a functional protein. Pseudogenes like this can arise via gene duplication or retrotransposition but typically lack protein-coding potential due to frameshifts, premature stop codons, or other disruptive mutations. The functional DOC2B protein is a vesicle priming protein that plays a role in glucose-stimulated insulin secretion in pancreatic beta cells, localizes to the inner plasma membrane and cytosol, and binds phospholipids via tandem C2 domains[4]. However, ENSG00000267295 does not encode a functional DOC2B protein, and there is no evidence it acts as a receptor, enzyme, transporter, or other classical drug target.\n\nKey distinctions:\n\n- This entry is not a classic drug target and should not be classified as a receptor, transporter, or enzyme.\n- It is incorrect to treat this pseudogene as a functional molecular target.\n- The functional gene/protein, DOC2B, is involved in beta cell biology and insulin secretion, but the pseudogene has no confirmed biological or clinical relevance[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double C2-like domains, beta pseudogene.